Arch Biopartners Inc.
TORONTO, A6 · CIK 0001600660 · Biotech · Private
LSALT peptide and Cilastatin drug candidates for acute kidney injury (AKI)
archbiopartners.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $631K
- 4 Form D · Jan 2015
- 141 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 6
- 4 granted · 2 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201320142015
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $70,000 | |
| Private capital raised | Form D · SEC | $140,000 | |
| Private capital raised | Form D · SEC | $155,519 | |
| Private capital raised | Form D · SEC | $265,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1477 | AstralBio, Inc. | — | $957K |
| 1478 | ACHERX LLC | — | — |
| 1479 | General LED, Inc. | — | $941K |
| 1480 | Arch Biopartners Inc. | — | $631K |
| 1481 | Eyevance Pharmaceuticals | — | — |
| 1482 | PROTHERA BIOLOGICS, INC. | — | $250K |
| 1483 | Modulate Bio Inc. | — | $200K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Claude AllaryDirector
- Andrew BishopDirector · Executive Officer
- Conor GunneDirector
- Adrian HaighDirector
- Jerome McElroyDirector
- Daniel MuruveExecutive Officer
- Richard MuruveDirector · Executive Officer
- Richard RossmanDirector
Patents
- DPEP-1 Binding Compositions and Methods of Usegranted
- DPEP-1 Binding Agents And Methods Of Useapplication
- DPEP-1 Binding Compositions and Methods of Usegranted
- DPEP-1 Binding Agents And Methods Of Useapplication
- DPEP-1 Binding Agents And Methods Of Usegranted
- DPEP-1 Binding Compositions And Methods Of Usegranted
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.